Initial STP705 Phase I Trial Results Show Fat Reduction
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.